Suppr超能文献

活动对预防内科患者静脉血栓栓塞的作用:我们目前的情况如何?

Role of ambulation to prevent venous thromboembolism in medical patients: where do we stand?

作者信息

Chindamo Maria Chiara, Marques Marcos Arêas

机构信息

Universidade Federal do Rio de Janeiro - UFRJ, Departamento de Clínica Médica, Rio de Janeiro, RJ, Brasil.

Rede D'Or São Luiz, Hospital Barra D'Or, Serviço de Clínica Médica, Rio de Janeiro, RJ, Brasil.

出版信息

J Vasc Bras. 2019 Jun 25;18:e20180107. doi: 10.1590/1677-5449.180107.

Abstract

Venous thromboembolism (VTE) encompasses the spectrum of manifestations of deep venous thrombosis and/or pulmonary embolism and is a common, serious, and preventable complication in hospitalized patients. Although immobility plays an important role in determining VTE risk in medical patients, no clear and uniform criteria exist to guide clinicians in assessing immobility. The variation in the descriptions that do exist makes it difficult to interpret and compare the results of randomized clinical trials with respect to the influence of different levels of immobility on the magnitude of VTE risk and the role that early ambulation as an isolated factor plays in prevention of such events. Understanding these limitations is a prerequisite for the proper use and interpretation of VTE risk assessment tools and for indicating the best strategy for preventing venous thrombosis in hospitalized medical patients. The objective of this study was to review the main evidence reported in the literature on the role of ambulation in prevention of VTE.

摘要

静脉血栓栓塞症(VTE)涵盖了深静脉血栓形成和/或肺栓塞的一系列表现,是住院患者常见、严重且可预防的并发症。尽管活动减少在确定内科患者VTE风险方面起着重要作用,但目前尚无明确统一的标准来指导临床医生评估活动减少情况。现有描述的差异使得难以解读和比较随机临床试验关于不同程度活动减少对VTE风险大小的影响以及早期活动作为独立因素在预防此类事件中所起作用的结果。了解这些局限性是正确使用和解读VTE风险评估工具以及指明预防住院内科患者静脉血栓形成最佳策略的先决条件。本研究的目的是回顾文献中报道的关于活动在预防VTE中作用的主要证据。

相似文献

1
Role of ambulation to prevent venous thromboembolism in medical patients: where do we stand?
J Vasc Bras. 2019 Jun 25;18:e20180107. doi: 10.1590/1677-5449.180107.
3
Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
J Vasc Nurs. 2008 Dec;26(4):109-17. doi: 10.1016/j.jvn.2008.09.005.
4
Variation in Definitions of Immobility in Pharmacological Thromboprophylaxis Clinical Trials in Medical Inpatients: A Systematic Review.
Clin Appl Thromb Hemost. 2018 Jan;24(1):13-21. doi: 10.1177/1076029616677802. Epub 2016 Nov 15.
6
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
8
Pentasaccharides for the prevention of venous thromboembolism.
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
9
A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease.
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1557-1567. doi: 10.1016/j.jvsv.2021.03.018. Epub 2021 Apr 16.
10
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.

引用本文的文献

1
Protocol for prophylaxis of venous thromboembolism in varicose vein surgery of the lower limbs.
Rev Col Bras Cir. 2022 Aug 22;49:e20223326. doi: 10.1590/0100-6991e-20223326-en. eCollection 2022.
3
Venous thromboembolism prophylaxis protocols at Brazilian hospitals - PROTEV Brazil.
J Vasc Bras. 2020 Jun 8;19:e20190119. doi: 10.1590/1677-5449.190119.
4
Following ISAPS Recommendations, Does it Really Help?
Aesthetic Plast Surg. 2021 Aug;45(4):1888-1894. doi: 10.1007/s00266-021-02174-x. Epub 2021 Feb 17.
5
Evidence-Based Minireview: Perioperative management of the VWD patient at elevated thrombotic risk.
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):601-603. doi: 10.1182/hematology.2019000078.

本文引用的文献

1
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.
2
Variation in Definitions of Immobility in Pharmacological Thromboprophylaxis Clinical Trials in Medical Inpatients: A Systematic Review.
Clin Appl Thromb Hemost. 2018 Jan;24(1):13-21. doi: 10.1177/1076029616677802. Epub 2016 Nov 15.
3
Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
Thromb Haemost. 2017 Apr 3;117(4):801-808. doi: 10.1160/TH16-08-0631. Epub 2017 Feb 2.
4
Early ambulation and prevention of post-operative thrombo-embolic risk.
J Visc Surg. 2016 Dec;153(6S):S11-S14. doi: 10.1016/j.jviscsurg.2016.09.002. Epub 2016 Oct 24.
5
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.
7
[Venous thromboprophylaxis in medical patients: an application review].
Rev Assoc Med Bras (1992). 2013 May-Jun;59(3):258-64. doi: 10.1016/j.ramb.2012.11.008. Epub 2013 May 13.
8
Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors.
Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):357-62. doi: 10.1177/1076029613481105. Epub 2013 Apr 22.
9
Developing a mobility protocol for early mobilization of patients in a surgical/trauma ICU.
Crit Care Res Pract. 2012;2012:964547. doi: 10.1155/2012/964547. Epub 2012 Dec 20.
10
Relevance of immobility and importance of risk assessment management for medically ill patients.
Clin Appl Thromb Hemost. 2013 Jun;19(3):268-76. doi: 10.1177/1076029612452781. Epub 2012 Jul 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验